FDA.reportPublic FDA data

HYDROXYPROPYL BETADEX

Substance profile for UNII 1I96OHX6EK, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for HYDROXYPROPYL BETADEX
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
1I96OHX6EK
Preferred term
HYDROXYPROPYL BETADEX
Registry number
128446-35-5
EC number
603-269-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C60H106O40
Chemical structure for HYDROXYPROPYL BETADEX
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

SMILES
CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1C[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7OCC(C)O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](OCC(C)O)[C@H]4O)[C@H](OC
RxCUI
1363608
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1363608mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1363608
FDA Substance Registration System1I96OHX6EKprecision.fda.gov/uniisearch/srs/unii/1I96OHX6EK
European Community number603-269-8commonchemistry.cas.org/results?q=603-269-8

DailyMed Socrata Ingredients#

Ingredient, DailyMed label, SPL version table
IngredientDailyMed labelSPL version
Hydroxypropyl .Beta.-CyclodextrinBB Cream1
HYDROXYPROPYL .BETA.-CYCLODEXTRINDrug Facts1
Hydroxypropylbetadex (0.58-0.68 MS)These highlights do not include all the information needed to use VIBATIV ® (telavancin) safely and effectively. See full prescribing information for VIBATIV. VIBATIV ® (telavancin) for injection, for intravenous use Initial U.S. Approval: 20099
HYDROXYPROPYL .BETA.-CYCLODEXTRINDrug Facts1
HYDROXYPROPYLBETADEX (0.58-0.68 MS)DRUG FACTS1
HYDROXYPROPYL .BETA.-CYCLODEXTRINSPORANOX (ITRACONAZOLE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.]16
Hydroxypropylbetadex (0.58-0.68 MS)VIBATIV (TELAVANCIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THERAVANCE BIOPHARMA ANTIBIOTICS, INC.]3
HYDROXYPROPYLBETADEX (0.58-0.68 MS)ALFAXAN (ALFAXALONE) INJECTION, SOLUTION [JUROX PTY. LIMITED]2
Hydroxypropylbetadex (0.58-0.68 MS)LEVENTA (LEVOTHYROXINE SODIUM) SOLUTION [SCHERING CORPORATION]2
Hydroxypropyl .Beta.-CyclodextrinDARK SPOT SUN DEFENSE BROAD SPECTRUM SPF 50 (TITANIUM DIOXIDE AND ZINC OXIDE) CREAM [DR. DENNIS GROSS SKINCARE™, LLC]1
HYDROXYPROPYL .BETA.-CYCLODEXTRINDYLOJECT (DICLOFENAC SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 1I96OHX6EK page 1 of 1 · 7 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYDROXYPROPYL BETADEX1I96OHX6EK94035026INJECTIONINTRAMUSCULAR1333 mg
HYDROXYPROPYL BETADEX1I96OHX6EK94035026INJECTIONINTRAVENOUS1333 mg
HYDROXYPROPYL BETADEX1I96OHX6EK94035026INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS9600 mg
HYDROXYPROPYL BETADEX1I96OHX6EK94035026CAPSULEORAL0.6 mg
HYDROXYPROPYL BETADEX1I96OHX6EK94035026SOLUTIONORAL8000 mg
HYDROXYPROPYL BETADEX1I96OHX6EK94035026TABLETORAL600 mg
HYDROXYPROPYL BETADEX1I96OHX6EK94035026TABLET, ORALLY DISINTEGRATINGORAL22 mg